trial · primary record
JNJ 56021927
Prostatic Neoplasms, Castration-Resistant
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 23 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Maximum Observed Plasma Concentration (Cmax) |
| Registry ID | NCT02592317 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:09.429Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02592317
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.